Tag: Treatment Innovation

Sanofi provides update on MOBILIZE phase 3 study of riliprubart in chronic inflammatory demyelinating polyneuropathy

Sanofi has announced the discontinuation of its Phase 3 MOBILIZE study evaluating…

ME Desk

FDA Grants Priority Review for GSK’s Bepirovirsen for Chronic Hepatitis B

The FDA has granted Priority Review to GSK’s bepirovirsen for chronic hepatitis…

Harshad Hussain B